Other genes that may potentially be linked to the occurrence of AM include tyrosine protein kinase (KIT), cyclin-dependent kinase inhibitor 2A (CDKN2A), and the v-raf murine sarcoma viral oncogene homolog B1 (BRAF) V600E mutation [20,21]. This evidence concerns the gene CDKN2A and acute myeloblastic leukemia with maturation.